Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.-Reference-Cited by-同舟云学术

Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.

Published:1990-11 Issue:5 Volume:82 Page:1668-1674
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Held P H¹,Teo K K¹,Yusuf S¹

Affiliation:

1. Clinical Trials Branch, National Heart, Lung and Blood Institute, Bethesda, Md 20892.

Abstract

An overview of eight randomized controlled trials of tissue-type plasminogen activator (Alteplase or Duteplase) and 10 of anisoylated plasminogen streptokinase activator complex (Anistreplase) showed that the odds of early death were reduced by 29% by tissue-type plasminogen activator and 46% by anisoylated plasminogen streptokinase activator complex, with overlapping 95% confidence intervals. Although the beneficial effects of both agents are consistent and are strengthened when all the trials are considered together, the available data do not permit comparisons of the relative efficacy of these two agents with each other or with streptokinase.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.82.5.1668

Reference30 articles.

1. Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Gruppo;Lancet,1986

2. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction;ISIS-2 (Second International Study Group of Infarct Survival) collaborative group;Lancet,1988

3. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

4. Topol EJ: Thrombolytic intervention in Topol EJ (ed): Textbook of Interventional Cardiology. Philadelphia WB Saunders Co 1990 pp 76-120

5. Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrinolytic drugs induced hemorrhage: mechanisms and solutions;Blood Coagulation & Fibrinolysis;2023-06-06

2. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results;Canadian Medical Association Journal;2005-03-01

3. Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex;Handbook of Experimental Pharmacology;2001

4. The Future of Glycoprotein IIb/IIIa Inhibitors;Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease;1999

5. ACUTE MYOCARDIAL INFARCTION AND CONGESTIVE HEART FAILURE;Emergency Medicine Clinics of North America;1996-02